Major
Bupropion × Metoprolol
Other antidepressants (NDRI)×Selective β1-adrenoceptor blockers
Mechanism
Bupropion is a potent CYP2D6 inhibitor, the main metoprolol metabolic route. Metoprolol plasma levels rise 4- to 5-fold. Risk of marked bradycardia and hypotension emerges.
Symptoms
Bradycardia (heart rate below 50/min), dizziness, syncope, orthostatic hypotension. In heart failure: worsening dyspnoea and oedema.
Management
Reduce metoprolol 2- to 3-fold when combined; monitor pulse and blood pressure. Alternative beta-blockers without CYP2D6 dependence: bisoprolol or carvedilol.
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.